Controlling Emesis with Chemotherapy
- New Agents -
Some references:
1
Rapoport, et al.
Lancet Oncol
2015.
2
Schwarzberg, et al.
Lancet Oncol
2015.
3
Aapro, et al
. Ann Oncol
2014;
4
Gralla, et al.
Ann Oncol
2014;
5
Navari et al.
N Engl J Med
2016
• Olanzapine
5
• A non-specific, non-selective, neuroleptic agent
• Questions persist regarding dose (5 or 10 mg), schedule and role
• Issue: side effect trade-off, sedation vs nausea